Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-064183)

Filing Details

Accession Number:: 0001209191-17-064183
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-06 16:24:27
Reporting Period:: 2017-12-04

Accepted Time:: 2017-12-06 16:24:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
57725	Lannett Co Inc	LCI	Pharmaceutical Preparations (2834)	230787699

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1262311	David Farber	13200 Townsend Road Philadelphia PA 19154		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-04	1,100	$30.01	4,190,169	No	4	S	Direct
Common Stock	Disposition	2017-12-05	8,716	$30.05	4,181,453	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Farber on November 22, 2017. The 10b5-1 trading plan will allow Mr. Farber to diversify a portion of his holdings consistent with SEC Rule 10b5-1 and the Company's Insider Trading Policy.